Elicio Therapeutics, Inc. (ELTX) Capital expenditures 2020–2025
Elicio Therapeutics, Inc. (ELTX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$16,000FY2025 · since FY2020: $41,000 → $16,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $16,000 | -81.6% |
| FY2024 | $87,000 | +31.8% |
| FY2023 | $66,000 | -89.9% |
| FY2022 | $654,000 | +71.2% |
| FY2021 | $382,000 | +831.7% |
| FY2020 | $41,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice